🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this trial is to assess the safety, efficacy, and tolerabi...
Status
Completed
Location
Rezolute Investigative Site, Phoenix, Arizona
Start Date
2023-02-06
Trial ID
NCT05712720
Primary Objective: To investigate the effectiveness of intravitreal applic...
Status
Unknown
Location
Marcelo Novello
Start Date
2013-03
Trial ID
NCT01824043
Treatments Being Tested
Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects with...
Status
Unknown
Location
Ocular Therapeutix Inc
Start Date
2023-01-15
Trial ID
NCT05695417
This is a two-step, multicenter, Phase I/II study including an open-label d...
Status
Active Not Recruiting
Location
Bascom Palmer Eye Institute/University of Miami
Start Date
2023-04-12
Trial ID
NCT05748873
Treatments Being Tested
The relationship between the surgical outcome of vitreous surgery for proli...
Status
Completed
Location
Kyorin Eye Center
Start Date
2008-09
Trial ID
NCT01307072
Treatments Being Tested
The study's main purpose is to asses the safety, tolerability, and effect o...
Status
Completed
Location
Arizona Retina and Vitreous Consultants
Start Date
2020-06-05
Trial ID
NCT04265261
The purpose of this study is to evaluate the safety and efficacy of oral/lo...
Status
Unknown
Location
Multiple Locations
Start Date
2017-03
Trial ID
NCT03038295
Treatments Being Tested
The purpose of this study is to evaluate the combined effects of diabetes s...
Status
Unknown
Location
Advantage Vision Center
Start Date
2020-01-01
Trial ID
NCT04120077
Treatments Being Tested
To evaluate the efficacy and safety of vitreoretinal surgery combined with ...
Status
Unknown
Location
Multiple Locations
Start Date
2018-09-01
Trial ID
NCT03633266
With the increasing incidence of proliferative diabetic retinopathy (PDR), ...
Status
Completed
Location
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine,
Start Date
2021-12-12
Trial ID
NCT05156021
Treatments Being Tested